ST Suwu (600200.SH): Lincomycin Hydrochloride Injection passes the generic drug consistency evaluation.

Wisdom Financial News APP, *ST Suwu (600200.SH) announced that recently, its wholly-owned subsidiary Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., a branch of the Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory (referred to as "Suzhou Pharmaceutical Factory"), received the "Notice of Approval of Drug Supplement Application" (Notice No.: 2025B04321) issued by the National Medical Products Administration for the "Lincomycin Hydrochloride Injection", and the drug has passed the evaluation of generic drug quality and efficacy consistency.